22-40861105-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_145174.2(DNAJB7):c.890G>A(p.Arg297His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000621 in 1,610,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_145174.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJB7 | NM_145174.2 | c.890G>A | p.Arg297His | missense_variant | 1/1 | ENST00000307221.5 | NP_660157.1 | |
XPNPEP3 | NM_022098.4 | c.64+3860C>T | intron_variant | ENST00000357137.9 | NP_071381.1 | |||
XPNPEP3 | NM_001204827.2 | c.*12+312C>T | intron_variant | NP_001191756.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJB7 | ENST00000307221.5 | c.890G>A | p.Arg297His | missense_variant | 1/1 | 6 | NM_145174.2 | ENSP00000307197.4 | ||
XPNPEP3 | ENST00000357137.9 | c.64+3860C>T | intron_variant | 1 | NM_022098.4 | ENSP00000349658.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 247744Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 133894
GnomAD4 exome AF: 0.00000549 AC: 8AN: 1458210Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 725312
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74340
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at